Canada Pension Plan Investment Board’s Teva Pharmaceuticals TEVA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.7M	Buy	1,556,933 +129,257	+9%	+$4.31M	0.03%	386
2026 Q1	$43M	Buy	1,427,676 +80,891	+6%	+$2.6M	0.03%	377
2025 Q4	$42M	Buy	1,346,785 +755,571	+128%	+$18.6M	0.03%	372
2025 Q3	$11.9M	Buy	591,214 +201,654	+52%	+$3.54M	0.01%	593
2025 Q2	$6.53M	Buy	389,560 +238,922	+159%	+$3.86M	0.01%	667
2025 Q1	$2.32M	Buy	150,638 +78,638	+109%	+$1.4M	﹤0.01%	790
2024 Q4	$1.59M	Hold	72,000	–	–	﹤0.01%	932
2024 Q3	$1.3M	Hold	72,000	–	–	﹤0.01%	948
2024 Q2	$1.17M	Hold	72,000	–	–	﹤0.01%	972
2024 Q1	$1.02M	Hold	72,000	–	–	﹤0.01%	1031
2023 Q4	$752K	Hold	72,000	–	–	﹤0.01%	986
2023 Q3	$734K	Hold	72,000	–	–	﹤0.01%	893
2023 Q2	$542K	Sell	72,000 -26,200	-27%	-$212K	﹤0.01%	900
2023 Q1	$869K	Hold	98,200	–	–	﹤0.01%	923
2022 Q4	$896K	Hold	98,200	–	–	﹤0.01%	876
2022 Q3	$792K	Hold	98,200	–	–	﹤0.01%	915
2022 Q2	$738K	Buy	+98,200	New	+$856K	﹤0.01%	880
2021 Q2	–	Sell	-143,000	Closed	-$1.65M	–	1355
2021 Q1	$1.65M	Sell	143,000 -35,586	-20%	-$408K	﹤0.01%	905
2020 Q4	$1.72M	Sell	178,586 -90,914	-34%	-$871K	﹤0.01%	864
2020 Q3	$2.43M	Buy	+269,500	New	+$2.85M	﹤0.01%	604
2019 Q4	–	Sell	-746,841	Closed	-$5.14M	–	1475
2019 Q3	$5.14M	Hold	746,841	–	–	0.01%	671
2019 Q2	$6.89M	Buy	+746,841	New	+$9.01M	0.01%	648
2019 Q1	–	Sell	-78,000	Closed	-$1.2M	–	1625
2018 Q4	$1.2M	Buy	+78,000	New	+$1.6M	﹤0.01%	1056
2017 Q2	–	Sell	-272,100	Closed	-$8.73M	–	1166
2017 Q1	$8.73M	Sell	272,100 -136,610	-33%	-$4.66M	0.02%	486
2016 Q4	$14.8M	Sell	408,710 -603,100	-60%	-$24.1M	0.05%	261
2016 Q3	$46.6M	Buy	1,011,810 +998,000	+7,227%	+$52.1M	0.17%	110
2016 Q2	$694K	Sell	13,810 -1,061,600	-99%	-$56.5M	﹤0.01%	829
2016 Q1	$57.5M	Buy	1,075,410 +442,200	+70%	+$25.9M	0.24%	78
2015 Q4	$41.6M	Sell	633,210 -555,500	-47%	-$34.3M	0.19%	85
2015 Q3	$67.1M	Buy	1,188,710 +519,109	+78%	+$33.7M	0.28%	62
2015 Q2	$39.6M	Sell	669,601 -85,000	-11%	-$5.24M	0.13%	137
2015 Q1	$47M	Sell	754,601 -137,709	-15%	-$8.01M	0.17%	118
2014 Q4	$51.3M	Hold	892,310	–	–	0.16%	113
2014 Q3	$48M	Buy	892,310 +38,900	+5%	+$2.06M	0.17%	109
2014 Q2	$44.7M	Sell	853,410 -150,000	-15%	-$7.67M	0.15%	126
2014 Q1	$53M	Buy	1,003,410 +307,827	+44%	+$14.2M	0.21%	102
2013 Q4	$27.9M	Sell	695,583 -421,900	-38%	-$16.6M	0.11%	185
2013 Q3	$42.2M	Buy	1,117,483 +15,100	+1%	+$589K	0.19%	127
2013 Q2	$43.2M	Buy	+1,102,383	New	+$42.9M	0.22%	119

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Canada Pension Plan Investment Board's TEVA Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Teva Pharmaceuticals (TEVA) stake by 9.1% in Q2 2026, buying an estimated $4.31M and bringing the position to 1,556,933 shares worth $52.7M. The position accounts for 0.03% of the portfolio, ranked #386.

Canada Pension Plan Investment Board first reported a position in TEVA in Q2 2013 and has held it in 39 quarters since. The position peaked at $67.1M in Q3 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Canada Pension Plan Investment Board held 1,556,933 shares of Teva Pharmaceuticals worth $52.7M as of Q2 2026.
Canada Pension Plan Investment Board bought 129,257 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.31M.
Teva Pharmaceuticals made up 0.03% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #386 holding.
Canada Pension Plan Investment Board first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
Canada Pension Plan Investment Board's Teva Pharmaceuticals position peaked at $67.1M in Q3 2015.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.